← All organizations
Highest phase reached
Phase 4
Timeline
1960s
- Jun 1, 1960
TTY Biopharm— Founded
2000s
- Feb 18, 2005
methimazole— Marketing Organization
Drugs by trial phase (26 distinct, 22 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (9 own, 0 via acquisition)
Phase 2 (11 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Biliary Tract Neoplasms
- Bipolar Disorder
- Body Weight
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Colorectal Neoplasms
- Dyssomnias
- Gastroesophageal Reflux
- Head and Neck Neoplasms
- Heartburn
- Laryngopharyngeal Reflux
- Lung Neoplasms
- Nasopharyngeal Carcinoma
- Pancreatic Neoplasms
- Parasomnias
- Sleep Wake Disorders
- Weight Loss
Marketed drugs (6)
Recent trials (22)
- NCT05359627Lead sponsorPhase 1May 31, 2022
- NCT04999332CollaboratorPhase 2Oct 1, 2021
- NCT04377048CollaboratorPhase 2Jul 1, 2020
- NCT04070313Lead sponsorPhase 2Jul 11, 2019
- NCT03316326CollaboratorPhase 2Nov 1, 2017
- NCT02761291CollaboratorPhase 1May 1, 2016
- NCT02980653Lead sponsorPhase 2May 1, 2015
- NCT02425137Lead sponsorPhase 2Apr 1, 2015
- NCT03669263CollaboratorN/ANov 25, 2014
- NCT02277886CollaboratorPhase 4Nov 1, 2014
- NCT03517618Lead sponsorPhase 2Jul 5, 2014
- NCT01946646CollaboratorPhase 1Oct 1, 2013
- NCT01450748Lead sponsorPhase 3Oct 1, 2011
- NCT01874678Lead sponsorN/AMar 1, 2011
- NCT02136030Lead sponsorN/AFeb 1, 2011
Details
- Founded
- Taipei, TW Jun 1, 1960
- Last known activity
- May 31, 2022